Gator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening Heart Failure
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years to 80 Years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
The primary objective of the study is to develop, implement, and evaluate a site-specific clinical pathway for at-home treatment of eligible patients presenting to the clinic with worsening heart failure. The secondary objectives are: 1. To evaluate patient factors related to parenteral decongestion at home. 2. To evaluate the safety and device operation of Lasix ONYU treatment under circumstances that mimic real-world use. 3. To identify opportunities for process improvement before the routine implementation of the new clinical pathway.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Inclusion Criteria: 1. Age 18 or above 2. Previously diagnosed with Congestive Heart Failure (HFpEF or HFrEF) 3. Fluid overload due to worsening HF requiring parenteral diuretic treatment as assessed by at least 2 of the following: 1. BNP \> 200 2. JVP \> 10cmH20 3. Presence of S3 4. LE Edema 5. Weight gain of \> 5lbs in the past 5 days 4. Failed oral uptitration of loop diuretic over the prior 5 days or presented with symptoms too advance to justify additional oral uptitration attempts to resolve congestion symptoms. 5. Expected to require a minimum of three days of parenteral diuretic treatment 6. Written informed consent 7. Able and willing to operate Lasix ONYU and comply with study requirements or has a caregiver who can assume these roles. Exclusion Criteria: 1. Age above 80 years 2. Unable or unwilling to provide informed consent. 3. Any medical condition or circumstances that would require further clinical investigation or hospitalization 4. Presence or history of electrolyte abnormalities that may be exacerbated by parenteral loop diuretic treatment 5. Home or current living environment not suitable for outpatient management and diuresis 6. Pregnant or breastfeeding 7. Unable to comply with clinic-required follow up procedure 8. Baseline chronic renal disease with CKD Stage V 9. Any surgical or medical condition which, in the opinion of the investigator, may pose an undue risk to the subject, interfere with participation in the study or which may affect the integrity of the data
Study sites (1)
FL
- University of Florida · Gainesville, FL 32608Mustafa Ahmed, MD · Study contactMore trials in Gainesville